Research location
Piracicaba
São Paulo, Brazil
Advertisement
Research activity in Piracicaba
São Paulo, BrazilCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Piracicaba
8 linked trials · page 1 of 1A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)NCT04961996 · 2021-08-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Effects of Respiratory Muscle Training in Obese WomenNCT03767556 · 2018-12-15 · 1 site observation
COMPLETED
Application Breathing Exercises With Load Inspiratory Postoperative Abdominal SurgeryNCT02298517 · 2013-12-01 · 1 site observation
COMPLETED
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)NCT01945775 · 2013-10-14 · 1 site observation
COMPLETED
Influence of Different Physical Therapy Resources Application After Reduction Stomach SurgeryNCT01872663 · 2013-08-01 · 1 site observation
COMPLETED
Use of Positive Pressure in Morbidly Obese Patients Undergoing Reduction Stomach SurgeryNCT01786681 · 2011-08-01 · 1 site observation
COMPLETED
A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal MetastasesNCT00699751 · 2008-06-12 · 1 site observation
COMPLETED
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabNCT00625898 · 2008-04-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.